Rivka Ishai-Michaeli

3.3k total citations · 1 hit paper
23 papers, 2.9k citations indexed

About

Rivka Ishai-Michaeli is a scholar working on Cell Biology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Rivka Ishai-Michaeli has authored 23 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cell Biology, 17 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Rivka Ishai-Michaeli's work include Proteoglycans and glycosaminoglycans research (21 papers), Fibroblast Growth Factor Research (12 papers) and Glycosylation and Glycoproteins Research (6 papers). Rivka Ishai-Michaeli is often cited by papers focused on Proteoglycans and glycosaminoglycans research (21 papers), Fibroblast Growth Factor Research (12 papers) and Glycosylation and Glycoproteins Research (6 papers). Rivka Ishai-Michaeli collaborates with scholars based in Israel, United States and Italy. Rivka Ishai-Michaeli's co-authors include Israël Vlodavsky, Michael Elkin, Iris Pecker, Yael Friedmann, Amiram Eldor, Ruth Atzmon, Zvi Fuks, Helena Aingorn, Orit Pappo and Yaacov Matzner and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Rivka Ishai-Michaeli

23 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis

1999 677 citations Israël Vlodavsky, Yael Friedmann et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rivka Ishai-Michaeli Israel	20	2.0k	2.0k	433	387	355	23	2.9k
Yael Friedmann Israel	18	2.1k 1.0×	2.1k 1.0×	351 0.8×	274 0.7×	336 0.9×	22	2.8k
Ruth Atzmon Israel	20	1.4k 0.7×	1.5k 0.7×	272 0.6×	280 0.7×	238 0.7×	23	2.2k
Vinata B. Lokeshwar United States	34	2.0k 1.0×	2.1k 1.1×	135 0.3×	335 0.9×	176 0.5×	58	3.4k
Anurag Purushothaman United States	19	963 0.5×	1.5k 0.8×	241 0.6×	653 1.7×	129 0.4×	24	2.0k
Manuela Schuksz United States	6	1.1k 0.5×	1.1k 0.6×	125 0.3×	124 0.3×	300 0.8×	8	1.7k
Ulla M. Ågren Finland	22	1.3k 0.6×	1.1k 0.6×	94 0.2×	176 0.5×	49 0.1×	27	2.0k
Eckart Bartnik Germany	26	471 0.2×	1.1k 0.6×	75 0.2×	482 1.2×	150 0.4×	48	2.4k
Paola Spessotto Italy	31	412 0.2×	1.1k 0.6×	174 0.4×	449 1.2×	114 0.3×	85	2.6k
Rachel Bar‐Shavit Israel	29	563 0.3×	1.4k 0.7×	1.5k 3.5×	920 2.4×	57 0.2×	71	3.4k
David J. Mahoney United Kingdom	20	867 0.4×	1.1k 0.5×	85 0.2×	136 0.4×	84 0.2×	22	2.1k

Countries citing papers authored by Rivka Ishai-Michaeli

Since Specialization

Citations

This map shows the geographic impact of Rivka Ishai-Michaeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rivka Ishai-Michaeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rivka Ishai-Michaeli more than expected).

Fields of papers citing papers by Rivka Ishai-Michaeli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rivka Ishai-Michaeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rivka Ishai-Michaeli. The network helps show where Rivka Ishai-Michaeli may publish in the future.

Co-authorship network of co-authors of Rivka Ishai-Michaeli

This figure shows the co-authorship network connecting the top 25 collaborators of Rivka Ishai-Michaeli. A scholar is included among the top collaborators of Rivka Ishai-Michaeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rivka Ishai-Michaeli. Rivka Ishai-Michaeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lerner, Immanuel, Esther Hermano, Eyal Zcharia, et al.. (2011). Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. Journal of Clinical Investigation. 121(5). 1709–1721. 163 indexed citations

Borsig, Lubor, Israël Vlodavsky, Rivka Ishai-Michaeli, Giangiacomo Torri, & Elena Vismara. (2011). Sulfated Hexasaccharides Attenuate Metastasis by Inhibition of P-selectin and Heparanase. Neoplasia. 13(5). 445–452. 39 indexed citations

Naggi, Annamaria, Benito Casu, Marta Pérez, et al.. (2005). Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting. Journal of Biological Chemistry. 280(13). 12103–12113. 190 indexed citations

Vlodavsky, Israël, Orit Pappo, Helena Aingorn, et al.. (2000). Mammalian heparanase as mediator of tumor metastasis and angiogenesis.. PubMed. 2 Suppl. 37–45. 42 indexed citations

Vlodavsky, Israël, Yael Friedmann, Michael Elkin, et al.. (1999). Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nature Medicine. 5(7). 793–802. 677 indexed citations breakdown →

Berman, Bluma, et al.. (1999). Similarities and Differences between the Effects of Heparin and Glypican-1 on the Bioactivity of Acidic Fibroblast Growth Factor and the Keratinocyte Growth Factor. Journal of Biological Chemistry. 274(51). 36132–36138. 41 indexed citations

Miao, Hua‐Quan, et al.. (1999). Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. International Journal of Cancer. 83(3). 424–431. 151 indexed citations

Medalion, Benjamin, Gideon Merin, Helena Aingorn, et al.. (1997). Endogenous Basic Fibroblast Growth Factor Displaced by Heparin From the Lumenal Surface of Human Blood Vessels Is Preferentially Sequestered by Injured Regions of the Vessel Wall. Circulation. 95(7). 1853–1862. 23 indexed citations

Miao, Hua‐Quan, Rivka Ishai-Michaeli, Ruth Atzmon, Tamar Peretz, & Israël Vlodavsky. (1996). Sulfate Moieties in the Subendothelial Extracellular Matrix Are Involved in Basic Fibroblast Growth Factor Sequestration, Dimerization, and Stimulation of Cell Proliferation. Journal of Biological Chemistry. 271(9). 4879–4886. 48 indexed citations

10.

Goshen, Ran, Abraham Hochberg, Rivka Ishai-Michaeli, et al.. (1996). Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Molecular Human Reproduction. 2(9). 679–684. 53 indexed citations

11.

Benezra, Miriam, et al.. (1993). Thrombin-induced release of active basic fibroblast growth factor- heparan sulfate complexes from subendothelial extracellular matrix. Blood. 81(12). 3324–3331. 64 indexed citations

12.

Ishai-Michaeli, Rivka, Carl M. Svahn, Michael Weber, et al.. (1992). Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix. Biochemistry. 31(7). 2080–2088. 78 indexed citations

13.

Vlodavsky, Israël, Amiram Eldor, Adriana Haimovitz‐Friedman, et al.. (1992). Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.. PubMed. 12(2). 112–27. 263 indexed citations

14.

Bashkin, Pnina, Rivka Ishai-Michaeli, Rachel Bar‐Shavit, et al.. (1991). Sequestration and Release of Basic Fibroblast Growth Factor^a. Annals of the New York Academy of Sciences. 638(1). 207–220. 37 indexed citations

15.

Vlodavsky, Israël, et al.. (1991). Heparan Sulfate Degradation in Tumor Cell Invasion and Neovascularization.. Trends in Glycoscience and Glycotechnology. 3(10). 82–90. 1 indexed citations

16.

Korner, Gil, et al.. (1990). Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer and Metastasis Reviews. 9(3). 203–226. 204 indexed citations

17.

Ishai-Michaeli, Rivka, Amiram Eldor, & Israël Vlodavsky. (1990). Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.. PubMed. 1(11). 833–842. 180 indexed citations

18.

Matzner, Yaacov, M Bar-Ner, Joachim Yahalom, et al.. (1985). Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.. Journal of Clinical Investigation. 76(4). 1306–1313. 191 indexed citations

19.

Bar-Ner, M, Michael D. Kramer, Volker Schirrmacher, et al.. (1985). Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. International Journal of Cancer. 35(4). 483–491. 66 indexed citations

20.

Melmed, Raphael N., Rivka Ishai-Michaeli, & Boris Yagen. (1985). Differential inhibition by T-2 toxin of total protein, DNA and isoprenoid synthesis in the culture macrophage cell line J774. Biochemical Pharmacology. 34(15). 2809–2812. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact